Want to see IN:ORCHPHARMA full AI Analyst Report?
Orchid Pharma Limited (ORCHPHARMA) Income Statement
Orchid Pharma Limited Income Statement
Last quarter (Q1 2027), Orchid Pharma Limited's total revenue was $3.04B, an increase of 75.89% from the same quarter last year. In Q1, Orchid Pharma Limited's net income was $32.24M. See Orchid Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 8.11B | $ 9.22B | $ 8.19B | $ 6.66B | $ 5.60B | |
| $ 1.59B | $ 3.55B | $ 1.36B | $ 706.89M | $ 2.32B | |
| $ 1.53B | $ 1.21B | $ 584.47M | $ 410.20M | $ 2.66B | |
| Depreciation and Amortization | $ 432.46M | $ 345.46M | $ 332.37M | $ 547.87M | $ 870.25M |
| $ 489.22M | $ 1.45B | $ 1.42B | $ 1.43B | $ 621.38M | |
| $ 56.76M | $ 811.13M | $ 777.04M | $ 296.69M | $ -338.90M | |
| $ 146.80M | $ 183.50M | $ 113.43M | $ 255.78M | $ -230.09M | |
| $ 203.55M | $ 994.63M | $ 890.47M | $ 552.47M | $ -568.99M | |
| $ 205.47M | $ 996.57M | $ 921.66M | $ 463.18M | $ -19.51M | |
| Per Share Metrics | |||||
| Basic EPS | $ 4.05 | $ 19.65 | $ 19.06 | $ 11.35 | $ -0.48 |
| Diluted EPS | $ 4.05 | $ 19.65 | $ 19.06 | $ 11.35 | $ -0.48 |
| Weighted Average Shares Outstanding | 50.73M | 50.72M | 48.37M | 40.82M | 40.82M |
| Weighted Average Shares Outstanding (Diluted) | 50.73M | 50.72M | 48.37M | 40.82M | 40.82M |
Currency in INR
